EpiCor® Increases Volume of Red Blood Cells and Boosts Immunity

Scientists have found that daily supplementation with EpiCor improved immune function, reduced inflammation and increased the volume of red blood cells in human subjects.
The scientists enrolled 25 healthy participants with an average age of 27.6 and randomly assigned them to receive daily EpiCor supplements (500 mg) or a placebo for five weeks. Among subjects taking EpiCor, there was an approximate 7 percent increase in volume of red blood cells (hematocrit). Moreover, the content of hemoglobin increased in red blood cells after EpiCor consumption compared to baseline, while the number of red blood cells did not increase. No significant change in red blood cells was observed in the placebo group. This increase in volume of red blood cells indicated that the RBCs being produced were healthier after EpiCor consumption, the researchers explained.
The researchers also noted that subjects consuming EpiCor experienced a mild increase in saliva levels of secretory IgA (sIgA), an antibody that coats the mucous membranes, thereby protecting against viral and bacterial invaders. The researchers followed up this sIgA aspect of the study with another subsequent 8-week trial. In this study of 22 subjects, there was a statistically significant increase in sIgA in participants given EpiCor.
Furthermore, an increase in levels of the anti-inflammatory cytokine interleukin-10 (IL-10) occurred after EpiCor use. The researchers noted other results, including the fact that seasonal allergies increased in the placebo group, but were not observed in the EpiCor group.
Reference:
Jensen GS, Patterson KM, Barnes J, Schauss AG, Beaman R, Reeves SG, Robinson LE. A Double-Blind Placebo-Controlled, Randomized Pilot Study: Consumption of a High-Metabolite Immunogen from Yeast Culture has Beneficial Effects on Erythrocyte Health and Mucosal Immune Protection in Healthy Subjects. The Open Nutrition Journal. 2008;2;68-75.